Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Pancreatic cancer (PaCa) is a highly lethal gastrointestinal malignancy.
• Reliability of microRNA (miRNA) findings as biomarkers for PaCa from single studies is unclear.

Purpose of the Study:

• To comprehensively investigate the diagnostic utility of miRNAs for pancreatic cancer.
• To assess the reliability of miRNA-based diagnostic findings through meta-analysis.

Main Methods:

• Systematic literature search of PubMed, Medline, Embase, Google Scholar, and CNKI databases.
• Meta-analysis of 29 studies including 2,225 PaCa patients and 1,618 controls.
• Evaluation of pooled sensitivity, specificity, and summary receiver operating characteristic (SROC) curve; heterogeneity assessed using I2 test.

Main Results:

• Pooled sensitivity: 82% (95% CI, 79-85%); specificity: 85% (95% CI, 79-89%); AUC: 0.89 (95% CI, 0.86-0.92).
• Subgroup analyses revealed significant differences between Caucasian and Asian populations in circulating miRNA analysis.
• Multiple miRNAs demonstrated higher diagnostic accuracy (SEN: 85%; SPE: 89%; AUC: 0.93) compared to single miRNAs (SEN: 78%; SPE: 79%; AUC: 0.84).

Conclusions:

• Multiple miRNAs show superior diagnostic performance for pancreatic cancer compared to single miRNAs.
• Circulating miRNAs hold potential as reliable biomarkers for pancreatic cancer diagnosis.
• Further studies are warranted to validate the diagnostic value of pooled miRNAs for PaCa.